Actively Recruiting
Study of How Caffeine Is Processed and Passed to the Baby in Pregnant Women Undergoing Cesarean Delivery
Led by Indiana University · Updated on 2026-06-04
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how pregnant bodies process caffeine and how much caffeine passes through the placenta to the baby. This pilot trial focuses on pregnant women at risk of preterm delivery during the second and third trimesters. The goal is to gather data to build a computer model of caffeine metabolism during pregnancy. Participants will receive a single intravenous dose of 100 mg caffeine citrate within about one hour before delivery by cesarean section. Blood samples will be collected before and after dosing from the mother, as well as from the placenta, umbilical cord, and newborn to measure caffeine and metabolite levels. This study is designed as a phase 1 interventional trial without masking. During the trial, pregnant participants will undergo blood draws to monitor caffeine levels over three hours after dosing, and placental transfer will be measured within one hour. The study includes informed consent and monitoring for safety, with a focus on pharmacokinetics and placental transfer of caffeine. The total participation involves delivery hospitalization and sample collection timed around delivery procedures.
CONDITIONS
Brief Title
Pharmacokinetics and Placental Transfer of Caffeine
Research Team
A
Anna E Thomas, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here